Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000555899 | SCV000655493 | benign | Nemaline myopathy 10 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001653921 | SCV001866593 | benign | not provided | 2019-09-06 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29923248) |
Ce |
RCV001653921 | SCV002821198 | benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | LMOD3: BS1, BS2 |
Molecular Genetics, |
RCV000555899 | SCV004812453 | benign | Nemaline myopathy 10 | 2023-05-04 | criteria provided, single submitter | clinical testing | European Non-Finnish population allele frequency is 1.729% (rs145387235, 2288/126934 alleles, 23 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.2.1, this variant is classified as BENIGN. Following criteria are met: BA1 |
Breakthrough Genomics, |
RCV001653921 | SCV005302217 | benign | not provided | criteria provided, single submitter | not provided |